Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 14 studies | 24% ± 7% | |
brain | 9 studies | 26% ± 12% | |
eye | 8 studies | 27% ± 14% | |
lung | 7 studies | 25% ± 7% | |
lymph node | 5 studies | 22% ± 1% | |
intestine | 4 studies | 23% ± 10% | |
pancreas | 3 studies | 47% ± 8% | |
kidney | 3 studies | 19% ± 0% | |
bone marrow | 3 studies | 21% ± 5% | |
liver | 3 studies | 27% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4463.46 | 2642 / 2642 | 100% | 27.68 | 705 / 705 |
breast | 100% | 3053.37 | 459 / 459 | 100% | 29.00 | 1118 / 1118 |
esophagus | 100% | 2657.94 | 1445 / 1445 | 100% | 28.14 | 183 / 183 |
ovary | 100% | 3808.84 | 180 / 180 | 100% | 24.16 | 430 / 430 |
lung | 100% | 2880.21 | 577 / 578 | 100% | 24.03 | 1155 / 1155 |
prostate | 100% | 3109.75 | 245 / 245 | 100% | 20.90 | 501 / 502 |
adrenal gland | 100% | 3515.81 | 258 / 258 | 100% | 22.86 | 229 / 230 |
uterus | 100% | 3256.84 | 170 / 170 | 100% | 23.44 | 457 / 459 |
thymus | 100% | 3998.87 | 653 / 653 | 100% | 34.09 | 602 / 605 |
kidney | 100% | 3138.76 | 89 / 89 | 99% | 24.08 | 896 / 901 |
bladder | 100% | 3094.62 | 21 / 21 | 99% | 20.95 | 501 / 504 |
stomach | 100% | 2405.21 | 359 / 359 | 99% | 22.62 | 284 / 286 |
pancreas | 100% | 2335.92 | 327 / 328 | 99% | 18.84 | 177 / 178 |
intestine | 100% | 3082.76 | 966 / 966 | 99% | 20.57 | 520 / 527 |
skin | 100% | 3362.41 | 1809 / 1809 | 98% | 22.60 | 462 / 472 |
liver | 100% | 1765.85 | 226 / 226 | 92% | 11.11 | 375 / 406 |
blood vessel | 100% | 3172.69 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.57 | 29 / 29 |
muscle | 100% | 4105.77 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3061.02 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.88 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.84 | 1 / 1 |
adipose | 100% | 2894.08 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 96% | 1987.25 | 823 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 14.03 | 74 / 80 |
peripheral blood | 88% | 2285.57 | 816 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0000290 | Biological process | deadenylation-dependent decapping of nuclear-transcribed mRNA |
GO_0035279 | Biological process | miRNA-mediated gene silencing by mRNA destabilization |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0060213 | Biological process | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening |
GO_0051607 | Biological process | defense response to virus |
GO_0033962 | Biological process | P-body assembly |
GO_0045070 | Biological process | positive regulation of viral genome replication |
GO_0006417 | Biological process | regulation of translation |
GO_1900153 | Biological process | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO_0031047 | Biological process | regulatory ncRNA-mediated gene silencing |
GO_0000289 | Biological process | nuclear-transcribed mRNA poly(A) tail shortening |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0000288 | Biological process | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO_0060339 | Biological process | negative regulation of type I interferon-mediated signaling pathway |
GO_0042509 | Biological process | regulation of tyrosine phosphorylation of STAT protein |
GO_0061014 | Biological process | positive regulation of mRNA catabolic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0030015 | Cellular component | CCR4-NOT core complex |
GO_0016020 | Cellular component | membrane |
GO_0016607 | Cellular component | nuclear speck |
GO_0000932 | Cellular component | P-body |
GO_0030014 | Cellular component | CCR4-NOT complex |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0043232 | Cellular component | intracellular non-membrane-bounded organelle |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0004532 | Molecular function | RNA exonuclease activity |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0000175 | Molecular function | 3'-5'-RNA exonuclease activity |
GO_0004535 | Molecular function | poly(A)-specific ribonuclease activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CNOT7 |
Protein name | CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (BTG1-binding factor 1) (CCR4-associated factor 1) (CAF-1) (Caf1a) CCR4-NOT transcription complex subunit 7 |
Synonyms | CAF1 |
Description | FUNCTION: Has 3'-5' poly(A) exoribonuclease activity for synthetic poly(A) RNA substrate . Its function seems to be partially redundant with that of CNOT8 . Catalytic component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation . During miRNA-mediated repression the complex seems also to act as translational repressor during translational initiation . Additional complex functions may be a consequence of its influence on mRNA expression . Associates with members of the BTG family such as TOB1 and BTG2 and is required for their anti-proliferative activity . . |
Accessions | E5RJE0 E5RHV9 ENST00000518021.5 E5RGH2 ENST00000519954.5 ENST00000520178.3 ENST00000628418.1 Q9UIV1 ENST00000361272.9 [Q9UIV1-1] ENST00000519918.5 ENST00000523917.5 [Q9UIV1-2] H0YAV9 E5RGA8 ENST00000518541.5 H0YBT3 ENST00000524358.5 |